ABT240726P80000
- 0.01
- -0.01-50.00%
Abbott Laboratories Newsroom
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device.This
Morgan Stanley Maintains Abbott Laboratories(ABT.US) With Hold Rating, Maintains Target Price $107
Morgan Stanley analyst Patrick Wood maintains $Abbott Laboratories(ABT.US)$ with a hold rating, and maintains the target price at $107.According to TipRanks data, the analyst has a success rate of 50.
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
What Are the Most Profitable Stocks of All Time? The Answer Might Surprise You.
An academic with a large following on Wall Street recently published a paper showing the stocks that have seen the strongest returns over time
Nephron Adjusts Price Target on Abbott Laboratories to $110 From $115
Abbott Laboratories (ABT) has an average outperform rating and a price target range of $104 to $143, according to analysts polled by Capital IQ.Price: 100.45, Change: +0.38, Percent Change: +0.38
Express News | Abbott : Raymond James Cuts Target Price to $122 From $124
BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
BTIG analyst Marie Thibault maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $135.According to TipRanks data, the analyst has a success rate of 31.7% and
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral" zone on Thursday.U.S. stocks closed lower on Thursday, with the Dow Jones
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
TD Cowen analyst Josh Jennings maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $130.According to TipRanks data, the analyst has a success rate of 53.1%
Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance
Abbott CEO Warns of Health Crisis If Preterm Formula Pulled -- Market Talk
1504 ET - Abbott Laboratories has been hit with hundreds of lawsuits alleging its preterm infant formula and human milk fortifiers cause a life-threatening gastrointestinal disease affecting
Why Are Abbott Laboratories Shares Trading Lower?
Shares of Abbott Laboratories (NYSE:ABT) are trading lower on Thursday following the company's second-quarter 2024 financial results.What's Going On: Abbott reported second-quarter sales of $10.377
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Thursday.The Dow traded down 1.08% to 40,752.05 while the NASDAQ fell 0.80% to 17,853.34.
Sector Update: Health Care
Health care stocks fell Thursday afternoon with the NYSE Health Care Index dropping 2.2% and the Health Care Select Sector SPDR Fund (XLV) down 1.7%.The iShares Biotechnology ETF (IBB) shed 0.8%.In
Express News | Abbott Laboratories Shares Are Trading Lower. The Company Reported Q2 Financial Results
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
Abbott Stock Dips After Raising Guidance, In-line Q2 Results
Least Shorted S&P 500 Stocks in June